This award is the largest federal grant ever given to Weill Cornell Medicine and represents 20 years of continuous funding for the CTSC under Dr. Imperato-McGinley’s direction.
In his last presentation at Medicine Grand Rounds, Dr. Hollenberg provided a slideshow of the many advances within WDOM. Dr. Hollenberg will be stepping down as Chair of the WDOM as of September 30, 2022.
Building upon his laboratory’s many discoveries centered around ILC3s, Dr. Gregory Sonnenberg has published another breakthrough in Nature (September 7, 2022).
Dr. Jedd Wolchok has been appointed as the Meyer Director of the Sandra and Edward Meyer Cancer Center and Dr. Taha Merghoub as Deputy Director.
An expert in the field of endocrinology, Dr. Mahler was beloved by patients, trainees, and colleagues alike.
WDOM is pleased to announce our Annual Report, covering activities spanning calendar year 2021. The department remains dedicated to its missions centered around clinical care, health equity, biomedical research, and education.
The Tri-institutional TB Research Advancement Center (TRAC) is a collaboration between an exceptional group of investigators at Weill Cornell Medicine, Cornell University, Rockefeller University, and Memorial Sloan Kettering Cancer Center.
The Medawar Prize is considered the world's highest dedicated award recognizing investigators whose contributions have had a profound influence on the field of organ transplantation.
This five-year, $1.25 million grant will enable Dr. Iliev to continue his innovative research into the relationship between certain types of fungi and specific cancers.
This award recognizes exceptional researchers whose scientific excellence and pioneering work have significantly advanced scientific development for the benefit of humanity.